Qiagen Added to the BCW Index; BD Dropped on Clontech Sale

This week marks the first roster change in BioCommerce Week's 10-month existence. Qiagen, a multi-platform molecular biology tools provider, competes with many of the players already covered by BioCommerce Week and has partnerships with others. The company has been very active in the molecular biology tools space and has made several moves this year to expand its product range and geographic reach (see table below). As such, the Dutch firm has been added to the Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.